// App-Quantinova.ai

WP280 : Use of Strategies to Improve Door-to-Needle Times with Tissue Plasminogen Activator in Acute Ischemic Stroke by US Hospitals: Findings from the Target: Stroke Survey

Researchers

Presenter

  • Eric E Smith

Principal Investigators

  • Xin Zhao

  • Eric D Peterson

  • Ying Xian

  • Dai Wai M Olson

  • Adrian F Hernandez

  • Deepak L Bhatt

  • Jeffrey L Saver

  • Lee H Schwamm

Medical Centers

  • Univ of Calgary, Calgary, Canada

  • Massachusetts General Hospital, Boston, MA

  • VA Boston Healthcare System, Boston, MA

  • Duke Clinical Research Institute, Durham, NC

  • Duke Clinical Res Ctr, Durham, NC

  • UCLA Care Center, Los Angeles, CA

  • UCLA Medcl Ctr, Los Angeles, CA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved